- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/13 - Cyclosporins
Patent holdings for IPC class A61K 38/13
Total number of patents in this class: 1197
10-year publication summary
|
103
|
105
|
112
|
128
|
147
|
114
|
95
|
86
|
78
|
45
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2155 |
44 |
| Breath Therapeutics GmbH | 30 |
25 |
| Novartis AG | 10174 |
23 |
| The Board of Trustees of the Leland Stanford Junior University | 6707 |
20 |
| Novaliq GmbH | 175 |
20 |
| Farsight Medical Technology (Shanghai) Co., Ltd. | 26 |
20 |
| The Regents of the University of California | 20868 |
16 |
| Aurinia Pharmaceuticals Inc. | 80 |
15 |
| Schepens Eye Research Institute | 65 |
14 |
| Sun Pharmaceutical Industries Limited | 722 |
14 |
| The General Hospital Corporation | 4881 |
13 |
| Sublimity Therapeutics Limited | 25 |
13 |
| Aneira Pharma, Inc. | 15 |
13 |
| Selecta Biosciences, Inc. | 168 |
11 |
| Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | 26 |
10 |
| Stealth Biotherapeutics Inc. | 195 |
10 |
| Enanta Pharmaceuticals, Inc. | 426 |
9 |
| Scynexis, Inc. | 68 |
9 |
| Seres Therapeutics, Inc. | 86 |
9 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1358 |
9 |
| Other owners | 880 |